Airway diseases
Respiratory critical care
Clinical trials session
ALERT: bronchiectasis and COVID
Aims : Including the ALERT sessions (Abstracts Leading to Evolution in
Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Methods :
Respiratory intensive care, General respiratory patient care
Discussants
H. Keir
Dundee (Angus)
(United Kingdom)
09:30
Introduction
1
RCT4266
09:36
RCT Abstract - The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial
C. Haworth(Cambridge, United Kingdom)
COI
2
09:43
Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)
C. Fernandez(Bridgewater, United States)
COI
3
09:50
Wrap-up by discussant and discussion
H. Keir(Dundee (Angus), United Kingdom)
COI
4
RCT4269
10:15
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
S. RAMAKRISHNAN(Nedlands, Australia)
COI
5
10:22
RCT Abstract - An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
B. Connolly(London, United Kingdom)
COI
6
10:29
Wrap-up by discussant and discussion
G. Rohde(Frankfurt am Main, Germany)
COI
7
RCT4272
10:54
Closing remarks
8
RCT4273
. . .
